Clinical Trials
3 trialsNCT03780517 2023-10-30
Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors
Boston Pharmaceuticals
Phase 1 Completed
NCT01539655 2017-05-02
Vandetanib
Sanofi
Phase 1 Completed
NCT00215605 2013-02-27
Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies
Exelixis
Phase 1 Completed